SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-013848
Filing Date
2013-11-05
Accepted
2013-11-05 09:07:14
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipxl20130930_10q.htm 10-Q 1875473
2 EXHIBIT 31.1 ex31-1.htm EX-31 13201
3 EXHIBIT 31.2 ex31-2.htm EX-31 14321
4 EXHIBIT 32.1 ex32-1.htm EX-32 6439
5 EXHIBIT 32.2 ex32-2.htm EX-32 6994
  Complete submission text file 0001437749-13-013848.txt   11617215

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS ipxl-20130930.xml EX-101.INS 2118869
7 EXHIBIT 101.SCH ipxl-20130930.xsd EX-101.SCH 79427
8 EXHIBIT 101.CAL ipxl-20130930_cal.xml EX-101.CAL 48968
9 EXHIBIT 101.DEF ipxl-20130930_def.xml EX-101.DEF 298785
10 EXHIBIT 101.LAB ipxl-20130930_lab.xml EX-101.LAB 497201
11 EXHIBIT 101.PRE ipxl-20130930_pre.xml EX-101.PRE 300938
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34263 | Film No.: 131191021
SIC: 2834 Pharmaceutical Preparations